DNA repair proteins act like the body's editors, constantly finding and reversing damage to our genetic code. Researchers have long struggled to understand how cancer cells hijack one of these ...

A study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.

Damaging variants in genes involved in a rapid immune response (innate immunity) are significantly linked to earlier breast ...

Discovery reshapes understanding of how tumor cells repair broken DNA, pointing toward more precise cancer therapies.

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

A new study from Dartmouth Cancer Center has found that a widely used blood pressure drug may help cancer treatments work ...

A new pan-cancer study has uncovered a shared vulnerability across multiple aggressive cancers and sheds light on the role ...